Bennicas & Associates’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $3.78M | Sell |
34,100
-650
| -2% | -$66.4K | 2.19% | 8 |
|
|
2022
Q3 | $2.99M | Sell |
34,750
-400
| -1% | -$35.7K | 1.91% | 9 |
|
|
2022
Q2 | $3.21M | Sell |
35,150
-300
| -0.8% | -$26.6K | 1.87% | 9 |
|
|
2022
Q1 | $2.91M | Sell |
35,450
-50
| -0.1% | -$3.94K | 1.46% | 20 |
|
|
2021
Q4 | $2.72M | Sell |
35,500
-300
| -0.8% | -$23.9K | 1.42% | 19 |
|
|
2021
Q3 | $2.69M | Sell |
35,800
-300
| -0.8% | -$22.8K | 1.51% | 15 |
|
|
2021
Q2 | $2.81M | Sell |
36,100
-1,733
| -5% | -$129K | 1.54% | 14 |
|
|
2021
Q1 | $2.78M | Sell |
37,833
-768
| -2% | -$56.7K | 1.6% | 13 |
|
|
2020
Q4 | $3.01M | Sell |
38,601
-157
| -0.4% | -$12K | 1.76% | 13 |
|
|
2020
Q3 | $3.07M | Sell |
38,758
-280
| -0.7% | -$21.9K | 1.91% | 12 |
|
|
2020
Q2 | $2.88M | Sell |
39,038
-314
| -0.8% | -$23.6K | 2.16% | 11 |
|
|
2020
Q1 | $2.89M | Sell |
39,352
-6,881
| -15% | -$541K | 2.55% | 9 |
|
|
2019
Q4 | $4.01M | Sell |
46,233
-2,796
| -6% | -$230K | 2.9% | 5 |
|
|
2019
Q3 | $3.94M | Hold |
49,029
| – | – | 3.05% | 5 |
|
|
2019
Q2 | $3.92M | Sell |
49,029
-864
| -2% | -$66.2K | 3.27% | 4 |
|
|
2019
Q1 | $3.96M | Sell |
49,893
-53
| -0.1% | -$3.96K | 3.48% | 3 |
|
|
2018
Q4 | $3.64M | Sell |
49,946
-1,362
| -3% | -$96.1K | 3.35% | 3 |
|
|
2018
Q3 | $3.47M | Hold |
51,308
| – | – | 3.01% | 4 |
|
|
2018
Q2 | $2.97M | Sell |
51,308
-314
| -0.6% | -$17.7K | 2.64% | 6 |
|
|
2018
Q1 | $2.68M | Sell |
51,622
-2,044
| -4% | -$110K | 2.4% | 7 |
|
|
2017
Q4 | $2.88M | Sell |
53,666
-2,523
| -4% | -$140K | 2.51% | 8 |
|
|
2017
Q3 | $3.43M | Sell |
56,189
-1,519
| -3% | -$92.1K | 2.92% | 5 |
|
|
2017
Q2 | $3.53M | Buy |
57,708
+60
| +0.1% | +$3.65K | 3.16% | 4 |
|
|
2017
Q1 | $3.5M | Sell |
57,648
-1,363
| -2% | -$82.7K | 3.12% | 3 |
|
|
2016
Q4 | $3.31M | Sell |
59,011
-105
| -0.2% | -$6.14K | 3% | 3 |
|
|
2016
Q3 | $3.52M | Buy |
59,116
+105
| +0.2% | +$6.14K | 3.2% | 2 |
|
|
2016
Q2 | $3.24M | Sell |
59,011
-1,153
| -2% | -$61.4K | 2.91% | 5 |
|
|
2016
Q1 | $3.04M | Sell |
60,164
-2,724
| -4% | -$133K | 2.89% | 4 |
|
|
2015
Q4 | $3.17M | Sell |
62,888
-315
| -0.5% | -$15.9K | 3.06% | 4 |
|
|
2015
Q3 | $2.98M | Sell |
63,203
-6,656
| -10% | -$354K | 2.78% | 4 |
|
|
2015
Q2 | $3.79M | Sell |
69,859
-1,030
| -1% | -$57.8K | 3.11% | 3 |
|
|
2015
Q1 | $3.89M | Sell |
70,889
-7,957
| -10% | -$451K | 3.26% | 2 |
|
|
2014
Q4 | $4.27M | Sell |
78,846
-1,684
| -2% | -$93.8K | 3.4% | 2 |
|
|
2014
Q3 | $4.55M | Sell |
80,530
-569
| -0.7% | -$32K | 3.75% | 2 |
|
|
2014
Q2 | $4.48M | Sell |
81,099
-472
| -0.6% | -$25.7K | 3.5% | 2 |
|
|
2014
Q1 | $4.42M | Sell |
81,571
-6,236
| -7% | -$323K | 3.53% | 2 |
|
|
2013
Q4 | $4.19M | Sell |
87,807
-14,960
| -15% | -$684K | 3.2% | 2 |
|
|
2013
Q3 | $4.67M | Sell |
102,767
-3,668
| -3% | -$167K | 3.37% | 2 |
|
|
2013
Q2 | $4.72M | Buy |
+106,435
| New | +$4.75M | 3.26% | 2 |
|
Other funds holding MRK
AWA
Bennicas & Associates's MRK Position: Q4 2022 in Review
Bennicas & Associates reduced its Merck (MRK) stake by 1.9% in Q4 2022, selling an estimated $66.4K and leaving 34,100 shares worth $3.78M. The position accounts for 2.19% of the portfolio, ranked #8.
Bennicas & Associates first reported a position in MRK in Q2 2013 and has held it in 39 quarters since. The position peaked at $4.72M in Q2 2013. 3,234 funds tracked by Wall St. Rank hold MRK as of Q4 2022.
- Bennicas & Associates held 34,100 shares of Merck worth $3.78M as of Q4 2022.
- Bennicas & Associates sold 650 Merck shares in Q4 2022, an estimated $66.4K.
- Merck made up 2.19% of Bennicas & Associates's portfolio in Q4 2022, its #8 holding.
- Bennicas & Associates first reported a position in Merck in Q2 2013 and has held it in 39 quarters since.
- Bennicas & Associates's Merck position peaked at $4.72M in Q2 2013.
- 3,234 funds tracked by Wall St. Rank held Merck as of Q4 2022.
Based on Bennicas & Associates's 13F filing for Q4 2022, filed 12 Jan 2023.